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Abstract: MicroRNAs (miRNAs) play crucial roles in regulating gene expression. Many studies show
that miRNAs have been linked to almost all kinds of disease. In addition, miRNAs are well preserved
in a variety of specimens, thereby making them ideal biomarkers for biosensing applications when
compared to traditional protein biomarkers. Conventional biosensors for miRNA require fluorescent
labeling, which is complicated, time-consuming, laborious, costly, and exhibits low sensitivity.
The detection of miRNA remains a big challenge due to their intrinsic properties such as small sizes,
low abundance, and high sequence similarity. A label-free biosensor can simplify the assay and
enable the direct detection of miRNA. The optical approach for a label-free miRNA sensor is very
promising and many assays have demonstrated ultra-sensitivity (aM) with a fast response time. Here,
we review the most relevant label-free microRNA optical biosensors and the nanomaterials used to
enhance the performance of the optical biosensors.
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1. Introduction
MicroRNAs (miRNAs) are endogenous tiny regulatory (~19–24 nucleotides in length) RNA species
found across plants, animals and humans. They play a critical role in the regulation of gene expression
by binding to mRNA targets to promote their degradation or repress their translation [1,2]. After the
discovery of the first miRNA in Caenorhabditis elegans in 1993 [3], a new era in molecular biology arose
and numerous studies have since reported on their mode of biogenesis and biological functions. A little
over 2600 unique miRNAs have been discovered in humans [4], animals [5], plants [6], and viruses [7,8].
Nearly all diseases, including diabetes [9–11], cardiovascular [12], cancer [13–15], fibrosis [16–19],
immunological [20] and neurodegenerative disorders [21–23] have been linked to an aberrant number
of miRNAs, misregulated miRNA signal pathways [24], or distinctive miRNA profiles [25]. It has
been shown that these miRNAs play an important role in numerous cellular processes and diseases,
and are well preserved in a variety human specimens, such as tissue, blood, or urine [26–29]. Further,
miRNAs have been shown to be measurable with a high degree of sensitivity and are therefore ideal
biomarker candidates in disease diagnosis when compared to traditional protein biomarkers that can
be easily degraded over time [30–32]. However, the accurate detection and quantification of miRNAs
remains a big challenge in the field of biosensing due to the current limitations of the analytical
tools available [32–37]. Conventional techniques used for assaying miRNAs [32,38], such as northern
blotting [39,40], quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), and cDNA
microarrays [41–43] are extremely complicated, time-consuming, laborious, cost-ineffective and exhibit
poor sensitivity. These challenges are attributed to the intrinsic properties of miRNAs such as their low
mass, short sequence length, high sequence similarity, low abundance (∼0.01% of the total mass), and
only a few molecules per cell [44–46].
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To date, optical based approaches are the most popular techniques in literature used for detecting
miRNAs and are widely studied in the development of biosensors [47–50]. Optical fluorescence-based
biosensors [46,51,52] that detect the hybridization between the miRNAs and their respective
complementary mRNA probes have been shown to be highly sensitivity using fluorescence
spectroscopy [53]. Although the use of fluorescent labeled miRNAs in the hybridization with the
immobilized probes generates a fluorescent signal that correlates with the presence of the target
miRNAs, this technique can result errors for the non-target detections and thereby impacting the
specificity of the biosensor. Precise labeling of each biomolecule results in a time-consuming process
and, usually, the labeling may further affect the function of the biomolecule. Additionally, it is very
difficult to quantify the captured miRNAs since the number of fluorophores per miRNA molecules
cannot be precisely controlled thereby resulting in a signal bias in the fluorescence intensity.
The label-free detection of biomolecules has been a long-standing goal in the development of
optical biosensors [48,49,54]. Label-free miRNA biosensors employ target miRNA biomolecules
in their natural state and are unlabeled or unmodified. The detection mechanism depends on the
measurement of the change in the intrinsic physical parameter of the biosensor, therefore resulting
in a cost-effective, more reliable, easy and faster detection of the biorecognition interaction in a
real-time. The physical parameter used in most label-free refractometric sensing devices is the index
of refraction [55]. The binding event induces a change in the index of refraction near the biosensor
surface and this biorecognition interaction is corelated to the biomolecule concentration. Label-free
optical biosensors have attracted a significant amount of intensive investigations in recent decades
due to their ability to employ ultra-small detection volume while achieving high sensitivity and low
limit of detection (LOD) in real-time. These characteristics enable label-free optical biosensors to be
advantageous over fluorescence-based biosensors since label-free biosensor signal does not depend on
the overall quantity of biomolecules in the sample detection volume.
Nevertheless, optical based methods are essential to achieve a robust, multiplexed analysis of
miRNA with high sensitivity and specificity and a large linear dynamic range. Optical biosensors
are highly desirable for detecting the interactions between biomolecules and have become more
versatile than other types of sensing technologies. In the following, we review some of the most
relevant miRNA label-free optical biosensor detection platforms, namely surface plasmon resonance
(SPR) based biosensors, interferometer-based biosensors, and whispering gallery mode (WGM)
microresonator-based biosensors, and the strategies used to detect ultralow concentrations of the target
miRNAs with and without an amplification strategy.
2. Surface Plasmon Resonance (SPR) Biosensors
Surface plasmon resonance (SPR) was initially applied to biosensing by Liedberg et al. [55]. Since
SPR biosensors have been widely used to detect various chemical and biological species such as cells,
bacteria, peptides, nucleic acids, proteins and viruses, they have become a very important instrument
for studying the interactions between target and biorecognition molecules [56–60]. SPR have also
gained significant attention in both fundamental research and industry after its commercialization in
1990 by Biacore (GE Health care). Currently, SPR biosensors are commercialized by many companies
all over the world [61] and have recently gained attention for miRNA detections [25,30,45,62–64].
The principle and applications of SPR biosensors have been well reviewed [56,57,60]. Here, we will
limit the scope to label-free detection using SPR biosensors.
Using SPR technology as an optical platform for biosensing, a surface plasma wave (SPW) that is
propagated along the metal-dielectric interface layer decays exponentially into the interfacing bulk
solution as the evanescent field (Figure 1a) [56,60,65,66]. The SPW propagation constant, β, is very
sensitive to the changes in the refractive index (RI) of the dielectric since a large portion of the SPW is
concentrated in the dielectric layer. The biorecognition event results in an increase in the local RI, n,
near the surface of the metal film (Figure 1b) that is optically detected as the transduction signal.
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The three most common methods used to excite the SPW [60] are prism coupling [67], waveguide 
coupling and grating coupling, wherein prism coupling with the attenuated total reflection (ATR) 
method (Figure 2a) has received significant attention [68–73]. A change of the propagation constant 
as a result of the biorecognition event induces a change in the coupling wavelength and hence a dip 
shift is observed (Figure 2b) using the ATR method. 
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Figure 2. (a) Surface plasmon resonance biosensor based on the attenuated total reflection (ATR) 
method and (b) spectrum shifts observed before and after change in the refractive index as the result 
of a biorecognition event. 
Several SPR-based approaches are based on microfluidic techniques for the detection of miRNA. 
A novel label-free portable SPR biosensor has been developed by Sipova et al. [71] for fast and 
sensitive detection of miR-122 acquired from mouse liver tissue. A DNA–RNA hybrid antibody-
based assay was employed to bind to the DNA–RNA hybrid structure. Figure 3a provides a schematic 
illustration of the surface modification of the electrode, wherein the first step involved the 
modification of the sensor surface with DNA probes to capture the target miRNA. In the presence of 
the analyte, the miRNA is captured and is subsequently recognized by the antibody that has an 
affinity to the DNA–RNA hybrids by binding to the miRNA–DNA duplex as shown in Step 2 of 
Figure 4a. The captured miRNA signal was significantly enhanced by the binding of the antibody to 
the miRNA–DNA duplex as depicted in the corresponding response (Figure 3b). In addition, the 
sensitivity of the assay was dramatically increased as a result [74,75]. The LOD for the direct detection 
of miR-122 was 100 pM and 2 pM LOD was observed using the antibody-amplified strategy. The SPR 
biosensor was further validated for miR-122 extracted from mouse liver tissue and the results agreed 
with those reported by qPCR. 
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Figure 2. (a) Surface plasmon resonance biosensor based on the at enuated total reflection (ATR)
method and (b) spectrum shifts observed before and after change in the ref active index as the result of
a biorecognition event.
Several SPR-based approaches are based on microfluidic techniques for the detection of iR A.
A novel label-free portable SPR biosensor has been developed by Sipova et al. [71] for fast and sensitive
detection of miR-122 acquired from mouse liver tissue. A DNA–RNA hybrid antibody-based assay was
employed to bind to the DNA–RNA hybrid structure. Figure 3a provides a schematic illustration of
the surface modification of the electrode, wherein the first step involved the modification of the sensor
surface with DNA probes to capture the target miRNA. In the presence of the analyte, the miRNA is
captured and is subsequently recognized by the antibody that has an affinity to the DNA–RNA hybrids
by binding to the miRNA–DNA duplex as shown in Step 2 of Figure 4a. The captured miRNA signal
was significantly enhanced by the binding of the antibody to the miRNA–DNA duplex as depicted
in the corresponding response (Figure 3b). In addition, the sensitivity of the assay was dramatically
increased as a result [74,75]. The LOD for the direct detection of miR-122 was 100 pM and 2 pM LOD
was observed using the antibody-amplified strategy. The SPR biosensor was further validated for
miR-122 extracted from mouse liver tissue and the results agreed with those reported by qPCR.
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Schmieder et al. [25] presented an optical system comprising a disposable SPR chip and 
microfluidic hybrid system as shown in Figure 4a. The system is coupled with a lateral imaging 
system to enable parallel analysis of three 1D spot arrays illuminated by three light channels on the 
gold surface (Figure 4b) to detect the target biomolecule. The disposable polymer-based biosensor 
chips (60 mm × 13 mm) were fabricated using injection molding technology and packaged to allow 
easy handling. The biosensor surface was sputter coated with a thin gold layer (45 nm) via magnetron 
sputtering [72]. The chip surface was functionalized with thiol-modified oligonucleotide probes to 
enable the hybridization of a locked nuclei acid oligo (LNA-93) to miRNA-93. LNA are typically used 
to enhance the probe affinity for its target among other functions. This approach provides high 
sensitivity and specificity. The target miRNA-93 was successfully detected using this label-free 
strategy with a limit of detection (LOD) of 10 nM. The LOD was further enhanced using an 
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Schmieder et al. [25] presented an optical system comprising a disposable SPR chip and microfluidic
hybrid system as shown in Figure 4a. The system is coupled with a lateral imaging system to enable
parallel analysis of three 1D spot arrays illuminated by three light channels on the gold surface (Figure 4b)
to detect the target biomolecule. The disposable polymer-based biosensor chips (60 mm × 13 mm) were
fabricated using injection molding technology and packaged to allow easy handling. The biosensor
surface was sputter coated with a thin gold layer (45 nm) via magnetron sputtering [72]. The chip
surface was functionalized with thiol-modified oligonucleotide probes to enable the hybridization
of a locked nuclei acid oligo (LNA-93) to miRNA-93. LNA are typically used to enhance the probe
affinity for its target among other functions. This approach provides high sensitivity and specificity.
The target miRNA-93 was successfully detected using this label-free strategy with a limit of etection
(LOD) of 10 nM. The LOD was further enhanced using an amplification step similar to Sipova et al. [71],
wherein an RNA–DNA-hybrid a tibody, which only binds to RNA–DNA double strands on the
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sensor surface, was employed to bind to the RNA–DNA hybrid structure. Therefore, upon successful
hybridization of miRNA-93 with LNA-93 probe, the antibody attached to the hybridized structure and
significantly enhanced the signal of the sensor with an improved LOD of 10 pM within 30 minutes.
In this approach, the LNA probes were demonstrated to be successful in enabling the direct label-free
detection of miRNA-93 and signal amplification was achieved using RNA–DNA-hybrid antibody.
This signal amplification strategy yields excellent results, and many studies have employed similar
amplification method (Table 1) whereby the overall mass or size of the target biomolecule is increased
via bioconjugation to other biomolecules or nanoparticles, and hence a significant enhancement of the
signal [45,75–78].
Table 1. Comparison of label-free microRNA optical sensors.
miRNA Type Sample Source Method LOD SampleVolume Reference
miR-16, miR-23b, and
miR-122b mouse liver tissue SPRi 10 fM 500 µL Fang 2006 [77]
miR-133b, miR-21, miR-24-1,
and let-7c U87 MG cells microrings 150 fM 75 µL. Qavi 2010 [73]
miR-16, miR-21, miR-24-1,
and miR-26a total mouse brain RNA microrings 10 pM 35 µL Qavi 2011 [78]
miR-21, and let-7a clinicalurine samples MZI 1 nM
70 µL (PBS)
200 mL (urine) Liu 2015 [31]
miR-let7a synthetic RNA MZI 202 pM – Liang 2017 [79]
miR-122 mouse liver tissue SPR 2 pM 440 µL Sipova 2010 [71]
miR-21 and miR-10b human plasma LSPR 23–35 fM 50 µL Joshi 2014 [62]
miR-10b human plasma LSPR aM 2.5 mL Joshi 2015 [63]
miR-15a Human plasma SPRi 0.56 fM Hu 2017 [75]
miR-93 synthetic RNA SPR 10 pM 25 µl Schmieder 2016 [25]
miR-21and miR-155 synthetic RNA LSPR 10 aM 5 µL Xue 2019 [44]
More recently, a SPR biosensor based antimonene was fabricated by Xue et al. [44] for the
label-free detection of miRNA-21 and miRNA-155. Antimonene is a two-dimensional nanomaterial
with delocalized 5s/5p orbitals and honeycomb lattice that results in a much stronger interaction with
ssDNA when compared to graphene-based DNA SPR biosensors. The synthesis of two-dimensional
antimonene nanosheet materials is shown in Figure 5a. A few layers of antimonene nanosheets
were obtained via sonication liquid-phase exfoliation [80], wherein the weak van der Waals forces
were broken and the presence of antimonene nanosheets in the solution were confirmed by the
Faraday–Tyndall effect [81] as shown in Figure 5b. The lateral dimensions of the antimonene nanosheets
used were greater than 300 nm with a thickness of approximately 3 nm.
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Figure 6 provides a schematic illustration of the antimonene-modified SPR biochips. The 
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6 provides a schematic illus ration of the antimonene-mo ified SPR biochips.
The antimonene nano he ts were assembled on gold film using a layer-by-layer (L = 4) approach
followe by the ads rptio of gold nanorods (AuNR) modified ssDNAs. The formation of
the AuNR-ssDNA complex was necessary to amplify the SPR signal through the extra mass
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added via the AuNRs. Various concentrations of miRNA were introduced to hybridize with
complementary AuNR-ssDNA adsorbed on the antimonene surface. The interaction between miRNA
with AuNR-ssDNA resulted in the formation of a double stranded DNA, which has a low affinity to
antimonene, thereby causing the hybridized target miRNAs to be released from the antimonene surface
and resulting in a shift in the SPR signal. The AuNR–ssDNA-modified antimonene SPR biosensor
exhibited a LOD of 10 aM. Compared to existing microRNA sensors, this was a 2.3–10,000 times
decrease in the limit of detection of miRNA biosensors (Table 1) and the highest sensitivity described
thus far in an optical based miRNA detection system.
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antimonene nanosheets casted on Au substrate. (II) AuNR-ssDNAs adsorption. (III) miRNA binds
to complementary AuNR-ssDNA to form a double-strand with complementary AuNR-ssDNA. (IV)
AuNR-ssDNA released from the antimonene nanosheets. Reproduced with permission from [44].
Copyright Springer Nature, 2019.
This antimonene based biosensor is the first SPR biosensor to use of two-dimensional antimonene
materials for clinically relevant miRNA detection. The application of antimonene is unique as it can
release the target biomolecules from the surface rather than retaining the miRNA on the biosensor
surface, as is the case for most SPR sensors. However, the impact of complex biological matrices on the
miRNA detection performance was not demonstrated with this SPR biosensor.
Overall, these results demonstrate that SPR biosensors can detect miRNAs. Despite the improved
sensing performance observed, the incorporation of an amplification step complicates the overall
biorecognition process, in addition to an increased in the analysis time. A total analysis time for
miRNA detection of approximately 30 minutes was achieved by Sipova et al. despite the additional
antibody (amplification) step and aM LOD was achieved using the two-dimensional antimonene
nanosheets by Xue et al. To improve the performance of the SPR sensors, other techniques, such as SPR
imaging (SPRi) [62], localized surface plasmon resonance (LSPR) [44,63,64], magneto-optical surface
plasmon resonance (MO-SPR) [82], long-range surface plasmon (LRSP) [83], and surface enhanced
Raman scattering (SERS) [84,85], have been integrated with SPR to achieve high sensitivities, as well as
to provide an extension to the highly multiplexed sensing architecture.
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2.1. SPR Imaging (SPRi)
Recently, SPRi and LSPR have gained significant attention in the area of miRNA biosensing.
SPRi is a label-free, high-throughput SPR biosensor (Figure 7) designed for measuring biomolecular
events simultaneously using an array of biomolecular elements chemically patterned on metallic
surfaces [57,86–88]. Compared with SPR, SPRi uses a CCD camera to acquire the SPR images and the
sensorgrams of the arrayed surface. Since the angle and wavelength of the propagating light are fixed,
the differences in the light intensities reflected in each array spots are correlated with the distribution
of the RI at the surface of the metal film. By this means, different biorecognition events can be detected
simultaneously in real time.
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A variety of strategies employing nanoparticles have been developed for the detection of miRNAs in
order to reduce the artifacts generated from the labeling and amplification steps. Recently, Fang et al. [77]
employed a nanotechnology-based strategy using polyadenylation (poly(A) polymerase enzyme)
chemistry combined with gold nanoparticle-amplification for SPRi detection of miRNAs from mouse
liver tissue. Figure 8 illustrates the detection mechanism employed for the identification of miRNAs.
LNAs were immobilized on the surface of the sensor to form LNA microarrays. The target miRNAs
were then introduced to hybridize with the LNA capture probes on the sensor surface. Poly(A) tails
were subsequently added to the surface bound miRNAs via the poly(A) polymerase surface reaction.
After this, the T30-coated AuNPs were added and allowed to hybridize with the poly(A) tails to
amplify the signal and enable the subsequent detection of the miRNAs via SPRi. This methodology
provided an ultrasensitive detection of miRNA through the combination of a surface-based enzyme
amplification and DNA-coated nanoparticle strategy [86,89–91]. A high sensitivity was achieved at fM
levels as the result of the strong hybridization afforded between the LNA-miRNAs and the poly(A)
tails-DNA-coated AuNPs. The 10-fold increase in the sensitivity of the microarray assays achieved
using this procedure is an improvement over the fluorescence based microarrays strategies currently
employed [92]. The nanotechnology-based assay was successfully demonstrated to quantify three
miRNA sequences from mouse liver: miR-16, miR-23b and miR-122b in a range from 20 fM to 2 pM
with a detection limit of 10 fM in total RNA sample [77].
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u et al. [75] fabricated an innovative SPRi sensing biochip that incorporates in-plane and vertical
signal amplification strategy for the direct detection of a multiple tumor biomarker, miRNA-15a at
sub-fM levels. The main idea behind the orthogonal signal amplification is to allow for additional mass
to be added to the target spot in-plane and upward from the sensor surface, thereby fully optimizing
the use of the 3D space for sample interrogation. The sensing biochip was fabricated with isolated gold
islands bordered by hydrophobic CYTOP (Figure 9) in order to construct 3D space for biomolecular
interactions. A 1.0 cm × 1.0 cm glass slide was coated with thin layer of chromium/gold (2 nm/48 n ),
which was processed using standard photolithography techniques to realize gold islands surrounded
by fluoropolymer CYTOP passivation layer. The direct detection of miRNA was realized by coupling
the miRNA-initiated cyclic D –DNA hybridization reaction along surficial direction on the target
probe with the DNA-initiated upward cyclic polymerization reaction. The unique aspect of this work
was that the amplification operation occurred in-plane and in the vertical directions. Since each
direction can have a 103-fold increase in the enhancement of the signal, a total of two directions
provides a net increase of 106-fold for the signal enhancement. This amplification method utilizing the
two dimensions resulted in ore mass being bound to the surface of the target sample. This approach
provides an effective use of the 3D space on and above a sample spot, thereby achieving a LOD
and limit of quantification down to 0.56 fM and 5 fM for miRNA-15a, respectively. This technique
resulted in about 107-fold increase in the sensitivity compared to traditional SPRi miRNA detection.
This strategy was further validated by quantifying miRNA-15a in blood samples from a healthy and
cancer patient. The results were found to be similar to those reported for colorectal cancer tissues.
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Figure 9. (A) Fabrication procedure for fabricating gold-islanded biochip with hydrophilic/hydrophobic
spacer: 1O gilding, 2O ph toresist spin-coating, 3O patterned exposure and developing, 4O gold etching,
5O CYTOP spin-coating and baking, 6O stripping excessive CYTOP and photoresist; (B) Ima e of the
chip wetted by water; (C) Image of the chip dropped with hydrophilic samples. Reproduced with
per ission from [75]. Copyright American Chemical Society, 2017.
Compared with the traditional SPR sensors, SPRi chips incorporating metallic nanostructures and
microfluidics make these optoflu dic devices ideal platforms for profiling miRNA in biological samples.
The signal amplification strategies employed ha e been proven t increase the detection signal and the
sensitivity Furthermore, the used of an orthogonal signal amplification, which employs two signal
amplification s eps wa shown to dramatically increase the detection signal by adding more mass onto
th target miRNA. The use of a secondary signal amplification strateg resulted in an improvement in
the LOD and therefore demonstr ted the potential to be implemente in diagnostic and point-of-c r
(POC) applic tions. Th refore, SPRi biosensors have emerged as one of the most pr mising optical
sensing techn ques to meet the demands for the implementation of lab-on-a-chip technologies [89].
2.2. Localized Surface Plasmon Resonance (LSPR)
With the recent development of nanotechnology and the manipulation of metallic structures
on the nanoscale, LSPR spectroscopy continues to garner attention and has demonstrated several
advantages beyond the traditional SPR due to their geometric dependent LSPR properties [90–92].
In brief, localized surface plasmons occurs when a light wave interacts with metallic nanoparticles
(NPs) that are much smaller than the incident wavelength (Figure 10) [93]. The interaction gives rise to
the free electrons in the metallic material to interact with the incident light and oscillate in phase with
the incident electric field, thus generating a localized surface plasmon resonance. At resonance, the
total electric field amplitude near the NPs can be increased substantially compared to the incident
amplitude. In addition, the resonant frequency is highly correlated to the properties of the NPs, such
as the NPs spatial distribution, chemical composition, size, geometry, and dielectric environment.
These properties have been explored in the development of biosensors where the biorecognition events
between the target analyte and the nanostructures modified with biorecognition elements result in the
modulation of the refractive index and a peak shift in the LSPR spectra.
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Figure 10. Schematic diagram for a localized surface plasmon excited in a small metallic particle.
Although there are many different configurations for generating LSPR spectra (transmission,
reflective geometry, dark-field scatteri g, etc.) [64], the most straightforward configuration is the
transmission-based spectroscopy shown in Figure 11. T is c nfiguration enables the LSPR biosensor
to monitor the extinction spectrum of the light passing t rough the sample without the use of prism,
thus making it a cost-effective appr ac that enables miniaturization [93,94]. In a study m tivated
by the development of a direct hybridization str tegy for detecting miRNAs in circulation pancreatic
cancer patients that is cost-effective, Joshi et al. [62] develop d a d demonstrated the first solid-st te
ultrasensitive LSPR biosensor for micr RNA that is both label-free and amplification-free.
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Figure 11. LSPR-based sensor using transmission attenuation configuration. Reproduced with
permission from [94]. Copyright MDPI, 2018.
The biosensor explored the unique properties of anisotropically shaped metallic nanostructure
(gold nanoprisms) by monitoring the LSPR dipole peak (λLSPR) [62,63] in physiological media (human
plasma). The gold nanoprisms were on average ∼35 nm in size (edge length) and exhibited an
unprecedentedly reversible 21 nm shifting towards longer wavelengths of the LSPR peak as a result of
the 0.6 nm thickness increase in the local dielectric environ ent [62]. The electromagnetic fields were
dramatically enhanced at the nanoprism’s sharp tips, which improved the enhancement of the Raman
scattering intensity of the analytes.
Figure 12 illustrates the mechanism of the direct hybridization strategy enabled by the plasmonic
biosensor fabricated by Joshi et al. [62]. The gold nanoprisms depicted in Figure 12a were chemically
synthesized and displayed an optimal λLSPR at ∼797 nm, which is well suitable for physiological
media such as blood and plasma. The gold nanoprisms were attached to a silanized glass support
platform followed by chemical functionalization with poly(ethyleneglycol)-6-thiols (PEG6-SH) and
the complementary probes (-C6-ssDNA). The PEG6-SH and ssDNA formed a self-assembled
monolayer (SAM) of biorecognition elements that provided the required space for hybridization
with co plementary miRNAs (Figure 12b). The PEG thiols were used as spacers to increase the
selectivity of the sensor by mini izing nonspecific adsorption and are not reactive toward miRNAs or
other biological components found in plasma. Upon the direct hybridization of the target miRNAs
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(miR-21 and miR-10b) to their complementary ssDNA, a shift in the λLSPR to longer wavelength was
observed in the biosensor response (Figure 12c). The total shift (∆λLSPR) observed was dependent on
the miRNA concentration (Figure 12d) and is used to determine the LOD (Figure 12e). The calculated
LODs for miR-21 in three different biological samples were found to be between 23−35 fM. This is more
than a 1000-fold decreased in the LOD when compared to label-free microring resonators [73] (Table 1)
and the nanopore based miRNA sensors [95], which employ an advanced fabrication procedures.
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Figure 13 provides the AFM micrograph of the change in surface area as a result of miR-21 
hybridization with mixed ssDNA-21 and PEG6-SH-functioanlized gold nanoprisms. The attachment 
of miRNAs to the sensor surface increased the thickness of the dielectric environment locally and 
therefore impacting the RI of the LSPR. The modulation in the LSPR properties resulted in the 
realization of an ultrasensitive label-free biosensor. A DNA-RNA cleaving enzyme, RNase H was 
used to break the bonds between the DNA-RNA duplex in order to regenerate the biosensor surface 
to allow for multiple assay cycles. This LSPR biosensor detected miRNA-21 and miRNA-10b in 
pancreatic cancer patient plasma at sub-fM concentration and miRNA-10b at the aM concentration 
level in pancreatic cancer cell lines, culture media and plasma. This plasmonic based biosensor could 
detect miRNAs in human plasma without sample preparation and thereby enabled the first label-free 
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Figure 12. Plasmonic biosensors based on nanoprisms: (a) Chemically synthesized gold nanoprisms
covalently attached onto glass coverslip via 3-mercaptopropyltriethoxysilane-functionalized. (b) Surface
modification of gold nanoprisms equi olar mixture of SH-C6-ssDNA-X and PEG6-SH in PBS buffer
(pH 7.4). (c) Incubation of sensor in miR-X solution and formation of DNA duplex. (d) Extinction
spectrum of the surface modification with SH-C6-ssDNA-X and PEG6-SH (blue curve) and after
incubation with miR-X (red curve). (e) Plot of ∆λLSPR versus log of miR-X concentrations. Reproduced
with permission from [62]. Copyright American Chemical Society, 2014.
Figure 13 provides the AFM micrograph of the change in surface area as a result of miR-21
hybridization with mixed ssDNA-21 and PEG6-SH-functioanlized gold nanoprisms. The attachment of
miRNAs to the sensor surface increased the thickness of the dielectric environment locally and therefore
impacting the RI of the LSPR. The modulation in the LSPR properties resulted in the realization of an
ultrasensitive label-free biosensor. A DNA-RNA cleaving enzyme, RNase H was used to break the
bonds between the DNA-RNA duplex in order to regenerate the biosensor surface to allow for multiple
assay cycles. This LSPR biosensor detected miRNA-21 and miRNA-10b in pancreatic cancer patient
plasma at sub-fM concentration and miRNA-10b at the aM concentration level in pancreatic cancer
cell lines, culture media and plasma. This plasmonic based biosensor could detect miRNAs in human
plasma without sample preparation and thereby enabled the first label-free and amplification-free
detection of miRNAs in complex, clinically relevant samples.
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A Mach–Zehnder interferometer (MZI) based miRNA detection system was fabricated by Liu et 
al. [31] for the label-free detection of multiple miRNAs in clinical relevant samples. The MZI 
Figure 13. Surface modification of LSPR sensor. (a) AFM micrographs after functionalization with 1:1
ratio of HS-C6-ssDNA-21/PEG6-SH (b) and after hybridization with 100 nM miR-21 in 40% human
plasma. (c) bare gold nanoprisms. (d) plot of the change in surface area of the gold nanoprisms after
each surface odification. Reproduced with permission from [62]. Copyright American Chemical
Society, 2014.
3. Integrated Planar Optical Waveguide Interferometer Biosensors
Integrated planar optical waveguide interferometer biosensors combine waveguiding and
interferometry approaches to measure the optical phase difference between the reference arm and
the probing arm by monitoring the interaction of the target molecules with evanescent field near the
surface of the sensor [79,96]. The Mach–Zehnder and Young interferometers illustrated in Figure 14a,b,
respectively, are extremely sensitive, exhibit extended dynamic range and interaction length when
compared with traditional SPR for changes in refractive index and surface mass density. However,
their integration is technologically complex [97] in terms of multiplexing.
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A Mach–Zehnder interferometer (MZI) based miRNA detection system was fabricated by
Liu et al. [31] for the label-free detection of multiple miRNAs in clinical relevant samples.
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The MZI biosensor was fabricated using standard complementary metal-oxide-semiconductor (CMOS)
fabrication process [97,98], where the waveguides and gratings were patterned on silicon wafer with
Si3N4 and oxide layers using deep UV lithography and reactive ion etching, followed by plasma
enhanced chemical vapor deposition of silicon oxide cladding layer. The biochip contains four identical
MZI sensors (Figure 15) with the waveguide splitting into two arms (reference and sensing arms)
which recombine at the opposite end to enable the multiplexed detection of miRNAs. The synthetic
target probes for target miRNAs was covalently immobilized on the amine functionalized biosensor
surface and the target miRNA in PBS solution was added via microfluidics to hybridize with the DNA
probe captured on the MZI biosensor surface. The hybridization reaction resulted in a phase change
that was measurable in terms of change in light intensity. Oligoribonucleotides and oligonucleotides
were used as the target probes for synthetic miR-21, let-7a and single nucleotide polymorphism of the
let-7 family of miRNAs. A LOD of 1 nM was achieved with the MZI system. The MZI miRNA-based
biosensor was successfully demonstrated in human urine samples to validate its clinically capability as
a point-of-care device; however, the LOD was not as low as previously reported for other biosensing
system (Table 1). The disposable MZI biochip is designed to be cost-effective, label-free, and eliminates
the need for temperature control or sophisticated detection system. Although the LOD was not as
impressive as other optical based biosensors, it detected the miRNA within 15 minutes and the LOD
can be improved by increasing the interaction length for biorecognition events, or by reducing noise
levels in the system.
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unique interferometer biosensor based on microfiber capillary optofludic biosensor was recently
reported by Liang et al. [79] to explore the interference spectrum during the biorecognition event
between DNA and miRNA. The combination of the microfiber and a capillary aligned and tapered
together formed what is known as a modal interferometer depicted in Figure 16. Figure 16a depicts
the fabrication process for the biosensor and Figure 16b,c provides the optical image and scanning
electron micrograph (SEM) of the as-fabricated biosensor, respectively. The biorecognition events
occur at the interior surface of the capillary and in turn induces the interference spectrum shift
ith the pre-im obilization of DNA probes. The optofluidic biosensor as de onstrated to detect
iR A-let7a with a log-linear range of 2 n to 20 µ and a L of 212 p ithout an a plification
step. The biosensor as also de onstrated to be capable of discri inating is atches in i s,
which is a desired characteristic for iR profiling. dditional benefits offered by the optofluidic
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miRNA biosensors is that it is amplification-free, portable, simple to fabricate and handle, thereby
enabling future applications beyond the benchtop.
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4. Whispering Gal ery odes ( i sensors
Optical biosensors based on his eri ller e ( G ) microresonators have attracted
significant attention in the last two decades due to their high sensitivity and low LOD [92,99,100].
An optical WGM resonator is a microstructure with smooth edges, such as microspheres, microrings,
microtoroids, microdisks, microbottles, microcapillaries and microbubbles, etc., and are made of
dielectric materials, with a relatively larger refractive index compared to the surrounding environment.
Due to the total internal reflection of the cavity surface, light can be confined in the resonator structure
as depicted in Figure 17. In general, the radius of the WGM resonator, R is much larger than the
resonant wavelength λ, i.e. R >> λ, to the first order approximation, and the resonance condition
happens when:
mλ = 2πrne f f
wher m is an integer, r is the outer radius of the res eff is the effective index. In another
word, when the total ength of a tri it equals an integer number of wav lengths, the
system is exactly on resonance. When a target molecule is captured on the surface of the resonator, the
WGM spectral position shift . The kinetic information f the binding ev nts near the surface of the
WGM resonator can be obtained by monitoring the WGM spectrum directly or indirectly.
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There are three main sensing mechanis s for resonator: mode shifting [101], mode
splitting [102], and mode broadening [103]. ode shift refers to the changes that occur in the resonant
wavelength of the resonator in the presence of the analyte of interest and is the most commonly
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used sensing mechanism for WGM resonators, due to its broad applicability to a range of analytes.
A key major disadvantage associated with mode shift is that it is susceptible to changes in ambient
conditions such as temperature, pressure, and humidity, and this tends to introduce unwanted
drift in the mode shift signal. However, mode shift sensing has been used to detect changes in
physical parameters surrounding WGM resonator, such as heat [104,105], pressure [106], and magnetic
fields [107]. Both mode splitting and mode broadening are self-referenced detection mechanisms
which can remove the influence of the environment temperature or system instability disturbance and
typically involve the adsorption of nanoparticles or a single biomolecule on the resonator surface.
Qavi et al. [73] reported a label-free detection system using commercially available multiplexable
array of microring resonators fabricated using silicon-on-insulator to analyze four miRNAs
simultaneously as shown in Figure 18a. The microring resonator system contained a total of
32 independently addressable microrings (φ = 30 µm) coated with a fluoropolymer cladding layer.
Figure 18b shows a SEM micrograph of the sensor array. The oxide-coated microring resonator were
covalently modified with ss-DNAs probes after which the target miRNA was flowed over the sensor
surface to hybridize to the complementary ss-DNA. The hybridization results in a shift in the resonance
wavelength (Figure 18c). The multiplexing capability was demonstrated in an experiment with
four arrays individually functionalized on the same chip with unique ssDNA complementary to
four different miRNAs (iR-133b, miR-21, miR-24-1, and let-7c). The miRNA specific responses were
observed at the microring resonators when the appropriate complementary miRNA solution flowed
over the sensor array and the biorecognition/ hybridization event was clearly observed. The LOD of
the microring resonator system was 150 fM without any amplification step and with a response time as
low as 10 minutes. In order to improve the sensitivity of the biosensor, an amplification step using
anti-DNA–RNA antibodies was incorporated to achieve the LOD microRNAs at 10 pM [78]. In the
amplification step, the anti-DNA–RNA antibody attached to the heteroduplexes selectively (Figure 19),
thereby resulting in an overall mass increase in the duplexes via the antibody (~150 kDa) and a larger
optical signal than those achieved with the original miRNA (~7 kDa) hybridization.
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5. Conclusions
The label-free and amplification-free ultrasensitive determination of miRNA is extremely
challenging. Most of the conventional clinical methods used to analyze microRNA require sample
transportation, laborious preparation steps, and skilled end-users. Although there are very limited
reports on the development of label-free miRNA based optical biosensors, the scientific literature
shows that there is a great deal of interest in miRNA assay development and this can be expected
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to continue to grow at an exponential rate. Label-free microRNA optical sensors provide rapid and
cost-effective approaches to achieve high sensitivity and LOD. A few groups have already demonstrated
the promising approaches of the optical miRNA biosensors by integrating nanomaterials due to their
unique optical properties and ability to enhance the optical signal. However, the addition of an
amplification step further complicates the sensor development process where multiple preparation
and detection steps are required.
It has been demonstrated that the label-free enzyme and DNA-coated AuNPs amplification
strategy employed using SPRi can be used to detect and quantify miRNAs down to fM levels with
very good sensitivity. Even lower limits of detection have been achieved by incorporating signal
amplification strategy down to the aM level using a more complicated assay format. The tapered
microfiber aligned silica capillary is one of the most cost effective, easy to fabricate optical biosensors
that offers a great degree of portability. Microring resonators have been successfully demonstrated
to achieve extremely low LOD for single molecule, however it is ultrasensitive to the point where
the optical signal is impacted by environmental conditions such as temperature, humility, electric or
magnetic field, etc. SPR based biosensors can offer sensitive, fast, and on-site analysis, and therefore,
they can be integrated with smart phone platforms in the development of POC systems for miRNA
detection and can serve as an alternative to conventional techniques.
The ability to measure miRNA at ultralow concentration levels with high selectivity in a variety of
biological samples is of great interest in clinical diagnostics and remains to be fully explored for human
specimens such as tissues, blood, or urine directly. The ideal optical biosensor for miRNA will require a
minimum or no sample preparation or pretreatment and will provide a great opportunity for the early
diagnosis of many diseases. Future research directions in this field may involve the implementation of
multiplexable arrays for the high throughput screening and complete profiling of miRNA in biological
relevant samples. Optical based biosensors have the potential to fully unravel miRNA biological
mechanisms and functions and to enable the development robust POC diagnostic systems.
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